ImportRefusal LogoImportRefusal

Laurus Labs Limited

⚠️ High Risk

FEI: 3007083664 • Anikapalli District, Andhra Pradesh • INDIA

FEI

FEI Number

3007083664

📍

Location

Anikapalli District, Andhra Pradesh

🇮🇳

Country

INDIA
🏢

Address

Plot No 18, & 21 Jawaharlal Nehru Pharma City; Parawada Mandal, Anikapalli District, Andhra Pradesh, India

High Risk

FDA Import Risk Assessment

53.7
LowModerateHighCritical

This firm has a significant history of FDA import refusals with notable violations.

Statistics

8
Total Refusals
3
Unique Violations
4/3/2024
Latest Refusal
2/22/2012
Earliest Refusal

Score Breakdown

Violation Severity
81.0×40%
Refusal Volume
35.3×30%
Recency
50.3×20%
Frequency
6.6×10%
How is this score calculated?

Proprietary Algorithm

  • 40% Violation Severity — AI-assessed (1-10)
  • 30% Refusal Volume — Logarithmic scale
  • 20% Recency — Decays over 5 years
  • 10% Frequency — Refusals per year

© ImportRefusal.com Original Analysis

Violation Summary

757×

UNAPPROVED

The article is subject to refusal of admission pursuant to Section 801(a)(3) in that it appears to be a new drug within the meaning of Section 201(p) without an approved New Drug Application (NDA).

1182×

NOT LISTED

It appears the drug or device is not included in a list required by Section 510(j), or a notice or other information respecting it was not provided as required by section 510(j) or 510(k).

22001×

DIET INGRE

The article is subject to refusal of admission pursuant to Section 801(a)(3) in that it appears to be for use as an ingredient in a dietary supplement and appears to be or may be otherwise unfit for food.

Refusal History

DateProductViolationsDivision
4/3/2024
62VCA73DOLUTEGRAVIR SODIUM (ANTI-VIRAL)
75UNAPPROVED
Division of Southeast Imports (DSEI)
4/3/2024
62VCA32LAMIVUDINE (ANTI-VIRAL)
75UNAPPROVED
Division of Southeast Imports (DSEI)
11/4/2020
62VDA15TENOFOVIR DISOPROXIL FUMERATE
75UNAPPROVED
Division of Southeast Imports (DSEI)
11/4/2020
62VCA32LAMIVUDINE (ANTI-VIRAL)
75UNAPPROVED
Division of Southeast Imports (DSEI)
11/4/2020
62VCA73DOLUTEGRAVIR SODIUM (ANTI-VIRAL)
75UNAPPROVED
Division of Southeast Imports (DSEI)
10/16/2013
60WCJ15HEXYLRESORCINOL (ANTHELMINTIC)
118NOT LISTED
75UNAPPROVED
New Orleans District Office (NOL-DO)
10/16/2013
60WCJ15HEXYLRESORCINOL (ANTHELMINTIC)
118NOT LISTED
75UNAPPROVED
New Orleans District Office (NOL-DO)
2/22/2012
54YBS99VITAMIN, MINERAL, PROTEINS AND UNCONVENTIONAL DIETARY SPECIALITIES FOR HUMANS AND ANIMALS, N.E.C.
2200DIET INGRE
Cincinnati District Office (CIN-DO)

Frequently Asked Questions

What is Laurus Labs Limited's FDA import refusal history?

Laurus Labs Limited (FEI: 3007083664) has 8 FDA import refusal record(s) in our database, spanning from 2/22/2012 to 4/3/2024.

What is an FEI number?

FEI stands for Firm Establishment Identifier. It's a unique number assigned by the FDA to identify establishments that manufacture, process, pack, or hold food, drugs, medical devices, or other FDA-regulated products. Laurus Labs Limited's FEI number is 3007083664.

What types of violations has Laurus Labs Limited received?

Laurus Labs Limited has been cited for 3 different violation type(s). Common FDA violations include adulteration (unsafe or unsanitary products), misbranding (incorrect or misleading labels), and regulatory non-compliance.

Where does this information about Laurus Labs Limited come from?

All FDA import refusal data for Laurus Labs Limited is sourced from the official FDA Data Dashboard (datadashboard.fda.gov), a public government database maintained by the U.S. Food and Drug Administration.

Data sourced from the FDA Data Dashboard, a public database maintained by the U.S. Food and Drug Administration.